Assignee
TRANSTHERA SCIENCES NANJING INC
CN·6 granted patents·12 pending applications·2 citations·filing 2019–2023
Top patents by PatentIndex Score
18 records- 0178US12234233B2Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereofTRANSTHERA SCIENCES NANJING INC·Filed 2020·Granted Feb 25, 2025·2 cites·19 claims
- 0267US11718620B2Method for treating a cancer mediated by abnormality of multi-kinasesTRANSTHERA SCIENCES NANJING INC·Filed 2020·Granted Aug 8, 2023·0 cites·20 claims
- 0361US2025152584A1Nlrp3 inflammasome inhibitor and uses thereofTRANSTHERA SCIENCES NANJING INC·Filed 2023·Application pending·0 cites
- 0458US2025082650A1Combined use of multikinase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 0558US2024190873A1Method for preparing phosphodiesterase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 0658US2024294542A1Nlrp3 inflammasome inhibitor and application thereofTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 0755US2024043408A1Crystal form of fibroblast growth factor receptor inhibitor and preparation method thereforTRANSTHERA SCIENCES NANJING INC·Filed 2021·Application pending·0 cites
- 0854US2024245704A1Pharmaceutical composition and use of multi-kinase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 0954US2025032504A1Novel application of kinase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 1052US2023129164A1Novel use of multikinase inhibitorTRANSTHERA SCIENCES NANJING INC·Filed 2021·Application pending·0 cites
- 1151US11420975B2Substituted imidazo[1,5-a]pyrazines as Bruton's tyrosine kinase inhibitorsTRANSTHERA SCIENCES NANJING INC·Filed 2022·Granted Aug 23, 2022·0 cites·5 claims
- 1251US2025163043A1Cdk9 inhibitor and use thereofTRANSTHERA SCIENCES NANJING INC·Filed 2022·Application pending·0 cites
- 1349US2022089593A1Pde9 inhibitor and use thereofTRANSTHERA SCIENCES NANJING INC·Filed 2020·Application pending·0 cites
- 1447US2023212167A1Method for synthesizing anti-tumor compound and intermediates thereofTRANSTHERA SCIENCES NANJING INC·Filed 2021·Application pending·0 cites
- 1546US12371432B2Haloallylamine compounds and application thereofTRANSTHERA SCIENCES NANJING INC·Filed 2020·Granted Jul 29, 2025·0 cites·19 claims
- 1645US2022298146A1Heterocyclic derivative and use thereofTRANSTHERA SCIENCES NANJING INC·Filed 2020·Application pending·0 cites
- 1739US12465601B2Uses of phosphodiesterase inhibitorsTRANSTHERA SCIENCES NANJING INC·Filed 2020·Granted Nov 11, 2025·0 cites·10 claims
- 1839US12291534B2Aminonorbornane derivative and manufacture method therefor and use thereofTRANSTHERA SCIENCES NANJING INC·Filed 2019·Granted May 6, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when TRANSTHERA SCIENCES NANJING INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →